YS Biopharma Co Ltd YS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:08 PM EDT
0.96quote price arrow down-0.0179 (-1.8305%)
Volume
4,312,180
Close
0.9779quote price arrow up+0.0278 (+2.9259%)
Volume
62,346
52 week range
0.35 - 1.78
Loading...
  • Open1.03
  • Day High1.03
  • Day Low0.95
  • Prev Close0.9501
  • 52 Week High1.78
  • 52 Week High Date06/13/23
  • 52 Week Low0.35
  • 52 Week Low Date02/02/24

Key Stats

  • Market Cap184.166M
  • Shares Out188.33M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change85.93

KEY STATS

  • Open1.03
  • Day High1.03
  • Day Low0.95
  • Prev Close0.9501
  • 52 Week High1.78
  • 52 Week High Date06/13/23
  • 52 Week Low0.35
  • 52 Week Low Date02/02/24
  • Market Cap184.166M
  • Shares Out188.33M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change85.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.56
  • P/E (TTM)-1.75
  • Fwd P/E (NTM)-0.06
  • EBITDA (TTM)-36.769M
  • ROE (TTM)9.47%
  • Revenue (TTM)77.688M
  • Gross Margin (TTM)80.05%
  • Net Margin (TTM)-55.08%
  • Debt To Equity (MRQ)97.78%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On YS Biopharma Co Ltd

 

Profile

MORE
YS Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001...
Yi Zhang
Chairman of the Board
Hui Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
Chunyuan Wu
Chief Financial Officer
Address
Beijing, BEJ
102629
China